1. U.S. Food and Drug Administration. Inactive Ingredient Field Descriptions. Available from: https://www.fda.gov/drugs/informationondrugs/ucm075230.htm. Last updated 15 May 2015.
2. THPdb: Database of FDA-approved peptide and protein therapeutics;SS Usmani;PLoS One,2017
3. U.S. Food and Drug Administration. Remarks from FDA Commissioner Scott Gottlieb, M.D., as prepared for delivery at the Brookings Institution on the release of the FDA’s Biosimilars Action Plan. July 2018.
4. U.S. Food and Drug Administration. Biosimilars Action Plan: Balancing Innovation and Competition. July 2018. Available from: https://www.fda.gov/media/114574/download
5. “Inactive” ingredients in oral medications;D Reker;Sci Transl Med,2019